531015
VENMAX
Start SIP
Invest Now
Start SIP in VENMAX
Performance
- Low
- ₹24
- High
- ₹27
- 52 Week Low
- ₹8
- 52 Week High
- ₹37
- Open Price₹24
- Previous Close₹26
- Volume1,177
Investment Returns
- Over 1 Month -6.8%
- Over 3 Month + 7.74%
- Over 6 Month + 5.07%
- Over 1 Year + 235.09%
Smart Investing Starts Here Start SIP with Venmax Drugs & Pharmaceuticals for Steady Growth!
Venmax Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 40.6
- PEG Ratio
- 0.2
- Market Cap Cr
- 14
- P/B Ratio
- Average True Range
- 1.9
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.38
- RSI
- 37.11
- MFI
- 4.98
Venmax Drugs & Pharmaceuticals Financials
Venmax Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹26.74
+
1.24
(4.86%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹27.98
- 50 Day
- ₹27.50
- 100 Day
- ₹26.83
- 200 Day
- ₹24.57
Resistance and Support
25.67
- R3 26.33
- R2 26.17
- R1 25.83
- S1 25.33
- S2 25.17
- S3 24.83
Venmax Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results | |
| 2025-09-02 | Amalgamation & A.G.M. | |
| 2025-08-16 | Others | Inter alia, to consider and approve 1. Allotment of Equity Shares pursuant to conversion of Convertible Equity Share Warrants. |
| 2025-07-23 | Quarterly Results | |
| 2025-05-09 | Audited Results |
Venmax Drugs & Pharmaceuticals F&O
About Venmax Drugs & Pharmaceuticals
- NSE Symbol
- VENMAX
- BSE Symbol
- 531015
- ISIN
- INE154G01022
Similar Stocks to Venmax Drugs & Pharmaceuticals
Venmax Drugs & Pharmaceuticals FAQs
Venmax Drugs & Pharmaceuticals share price is ₹26 As on 11 December, 2025 | 14:15
The Market Cap of Venmax Drugs & Pharmaceuticals is ₹14 Cr As on 11 December, 2025 | 14:15
The P/E ratio of Venmax Drugs & Pharmaceuticals is 40.6 As on 11 December, 2025 | 14:15
The PB ratio of Venmax Drugs & Pharmaceuticals is -21.2 As on 11 December, 2025 | 14:15
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.